tenofovir has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baxi, SM; Choden, T; Desai, M; Dorjee, K; Hubbard, AE; Reingold, AL | 1 |
| Walter, M | 1 |
| Bedimo, RJ; Drechsler, H; Tebas, P; Vidiella, G; Westfall, AO | 1 |
3 other study(ies) available for tenofovir and Myocardial Infarction
| Article | Year |
|---|---|
Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States.
Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; HIV Infections; HIV-1; Humans; Lamivudine; Myocardial Infarction; Tenofovir; United States | 2021 |
[Current data on antiretroviral therapy. CROI 2009: tenofovir DR convinces by high effectiveness and tolerance].
Topics: Adenine; Algorithms; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Dideoxynucleosides; Humans; Myocardial Infarction; Organophosphonates; Tenofovir; Treatment Outcome | 2009 |
Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Female; HIV Infections; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Organophosphonates; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Stroke; Tenofovir; United States; United States Department of Veterans Affairs | 2011 |